Rare Disease Consulting

Due to their low occurrence and specific regulatory requirements, rare diseases present unique challenges in treatment development, evidence generation, and commercialization. We have a team with the knowledge and experience to support your decision making at all stages of product development.

Rare disease consulting solutions

Developing and launching new rare disease therapies can pose several unique challenges. We provide the required expertise to help you navigate these barriers.

An expert team to support product development and launch

Our experience in rare diseases spans all stages, from product development, market assessment, and asset prioritization through to real-world evidence generation and consulting support for commercialization. Our global, multidisciplinary team of experts takes a pragmatic, modular, and flexible approach to engagements. We’re proud to have conducted more 600 studies on rare diseases around the world, providing a strong knowledge base for determining study feasibility and optimizing design and execution.

Rich and relevant data from multiple trusted sources

We follow a data-first strategy, combining diverse data sources for deeper insights. Our first step is to determine what existing data is available, which can be very limited for rare diseases. We can also create custom primary studies, databases, or registries using direct-to-patient or site-based methods. Alternatively, we can adopt a hybrid approach, combining new and existing data. Ultimately, our goal is to access or generate the best achievable data for the situation.

Eliciting deep insights with care and sensitivity

To fully understand how decisions are made, you must understand the person behind the patient, caregiver, or healthcare provider. This is particularly true for rare disease research, where sufferers can be young, medical knowledge is often sparse, and the treatment journey is typically quite complex. Our team takes special care to ensure research is conducted sensitively, with empathy and without judgment.

Strong operational skills to reach the relevant stakeholders

Identifying the right stakeholders is key to understanding how a rare disease is diagnosed and treated. We have a proven track record of accessing patients, patient organizations and advocacy groups, caregivers, key opinion leaders, clinicians, and payers. We tailor our recruitment strategies to the needs of the indication to provide the insight and evidence you need for strategic decision-making.

从 Oracle 生命科学开始


订阅博客

了解最新观点和优秀实践,助力临床成功。


获取技术支持

了解技术支持团队联系方式和资源。


关注我们的播客

了解思想领袖关于生命科学行业趋势的真知灼见。


联系我们

联系我们,了解关于临床研究和药物警戒的更多信息。

注:为免疑义,本网页所用以下术语专指以下含义:

  1. Oracle专指Oracle境外公司而非甲骨文中国。
  2. 相关Cloud或云术语均指代Oracle境外公司提供的云技术或其解决方案。